How Do I Know If I Have PCOS? Signs, Symptoms & Next Steps

How Do I Know If I Have PCOS? Signs, Symptoms & Next Steps

You likely have PCOS if you experience at least two of three criteria: irregular or absent periods, elevated androgens (detected by blood test or physical signs like excess facial hair or persistent acne), and polycystic-appearing ovaries on ultrasound. The main caveat is that all three don't have to be present simultaneously — diagnosis requires only two. The exception is anyone already diagnosed with another condition that mimics PCOS, such as congenital adrenal hyperplasia or a hormone-secreting tumor, which must be ruled out first.

---

What Is PCOS and Why Is It So Often Missed?

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, affecting an estimated 6–12% of the population in the United States (CDC, 2023). Despite being this prevalent, the average time from first symptom to diagnosis is two years, with some women waiting nearly a decade.

The delay exists for a few reasons. First, PCOS is a syndrome — a cluster of symptoms rather than a single disease — meaning no two presentations are identical. Second, many of its hallmarks (weight gain, acne, fatigue, mood changes) are easily attributed to stress, diet, or aging. Third, a diagnosis of exclusion is required: your clinician must first rule out thyroid dysfunction, hyperprolactinemia, and adrenal disorders before confirming PCOS.

If you've been wondering how to recognize the signs of PCOS for a while without clear answers, understanding the formal diagnostic framework is where to start.

---

The Rotterdam Criteria: The Diagnostic Gold Standard

The most widely used diagnostic framework is the 2003 Rotterdam consensus criteria, which requires at least two of the following three features:

1. Oligo- or anovulation — cycles longer than 35 days, fewer than eight periods per year, or complete absence of menstruation
2. Clinical or biochemical hyperandrogenism — elevated testosterone, DHEA-S, or free androgen index on blood work, OR physical signs such as hirsutism (excess male-pattern hair growth), acne, or androgenic alopecia
3. Polycystic ovarian morphology (PCOM) — 12 or more follicles measuring 2–9 mm in diameter in at least one ovary, or an ovarian volume exceeding 10 mL on ultrasound

Importantly, having polycystic-appearing ovaries on ultrasound alone does NOT equal a PCOS diagnosis. Up to 25% of women with normal cycles and no androgen excess have polycystic ovarian morphology on imaging (Azziz et al., Journal of Clinical Endocrinology & Metabolism 2004; PMID: 15181022). The Rotterdam criteria were explicitly designed to prevent over-diagnosis on ultrasound findings alone.

The criteria also produce four distinct PCOS phenotypes:

Phenotype D is the most controversial — some endocrinologists argue it shouldn't carry the PCOS label at all because it lacks the androgen excess that drives the bulk of long-term metabolic risk. This distinction matters when you're interpreting your own lab results.

---

Key Lab Tests That Confirm — or Rule Out — PCOS

A clinical suspicion of PCOS needs to be backed by specific bloodwork. Below are the tests most commonly ordered, what they measure, and what results typically indicate:

Insulin resistance, while not part of the diagnostic criteria, is present in approximately 65–80% of women with PCOS regardless of body weight (Diamanti-Kandarakis & Dunaif, Endocrine Reviews 2012; PMID: 23065822). This is why fasting insulin and glucose are valuable even if your clinician doesn't immediately order them — you can ask.

---

Found Out That Something Else Was Making Symptoms Worse: Ruling Out Tumors and Other Mimics

This is one of the most important — and most underappreciated — parts of the diagnostic process. A subset of women who initially receive a PCOS diagnosis later discover that a different condition was the primary driver, or was compounding their symptoms.

Androgen-secreting tumors (ovarian or adrenal) can produce rapidly progressing hirsutism, clitoral enlargement, and testosterone levels often exceeding 150–200 ng/dL. The rate of rise matters: PCOS-related androgen excess develops gradually, whereas tumor-driven excess typically escalates over weeks to months. If your testosterone is very high or your symptoms appeared suddenly, imaging of the adrenals and ovaries is warranted before accepting a PCOS label (Carmina et al., Endocrine Reviews 2006; PMID: 16614255).

Congenital adrenal hyperplasia (CAH), specifically the non-classic form, mimics PCOS almost exactly. It accounts for roughly 1–10% of women presenting with PCOS-like symptoms depending on ethnicity. A morning 17-hydroxyprogesterone (17-OHP) level above 200 ng/dL should prompt an ACTH stimulation test.

Cushing's syndrome (cortisol excess) produces weight gain concentrated around the abdomen, irregular cycles, acne, and fatigue — an overlap so complete that Cushing's is often misdiagnosed as PCOS for years. A 24-hour urinary free cortisol or overnight dexamethasone suppression test can differentiate the two.

Hyperprolactinemia (often from a pituitary microadenoma called a prolactinoma) suppresses ovulation and causes irregular cycles. A single prolactin blood draw — ideally drawn without recent stress, exercise, or breast stimulation — is usually sufficient to screen for this.

The clinical message: if your symptoms are severe, rapidly progressing, or don't respond to standard PCOS interventions, push for imaging and the additional hormone panels above.

---

PCOS, Nausea, and Dizziness: Symptoms That Often Go Unexplained

Nausea and dizziness are not listed in the diagnostic criteria, yet they appear frequently in community accounts from women with PCOS — and there are plausible mechanisms behind them.

Hypoglycemia and blood sugar instability are common in women with significant insulin resistance. After a carbohydrate-heavy meal, exaggerated insulin release can cause a rapid glucose drop one to three hours later, producing shakiness, light-headedness, nausea, and brain fog. This reactive hypoglycemia is distinct from fasting hypoglycemia but can be just as disruptive.

Elevated LH surges in some PCOS phenotypes can cause brief waves of nausea similar to early pregnancy symptoms, particularly around mid-cycle when LH spikes are most pronounced.

Autonomic dysregulation has been documented in PCOS, with some research noting altered heart rate variability and vasomotor instability — both of which can contribute to positional dizziness (Tekin et al., Gynecological Endocrinology 2010; PMID: 20201661).

If you're experiencing regular nausea or dizziness, track whether they cluster around meals (suggesting glycemic instability), around cycle day 12–14 (suggesting LH-driven), or occur randomly throughout the month. That pattern gives your clinician something concrete to work with.

---

PCOS Weight Gain: Why the Middle Is the Target

If you've noticed weight accumulating disproportionately around your waist, this is consistent with the PCOS metabolic profile — but it has a specific mechanism worth understanding. Hyperinsulinemia drives fat storage preferentially in visceral (intra-abdominal) depots rather than subcutaneous fat, because visceral adipocytes are more sensitive to insulin's lipogenic effects.

Visceral fat is metabolically active in a problematic way: it secretes inflammatory cytokines including TNF-α and IL-6, which worsen insulin resistance further, creating a feedback loop (Escobar-Morreale et al., Human Reproduction Update 2011; PMID: 21135156). This is why weight gain around the middle in PCOS is not simply a calorie question — it's driven by hormonal signaling that standard diet advice doesn't fully address.

Waist circumference above 35 inches in women is associated with substantially elevated cardiometabolic risk, independent of BMI. Importantly, lean women with PCOS (roughly 20–30% of the PCOS population) can have elevated visceral fat and insulin resistance despite a healthy body weight — meaning normal BMI does not rule out metabolic PCOS. You can also read more about what causes weight gain around the middle in PCOS and the hormonal drivers in detail.

---

Sleep Problems in PCOS: Why Insomnia Is More Than Stress

Insomnia and non-restorative sleep are reported by a large proportion of women with PCOS, yet they rarely make it onto the standard symptom checklist clinicians use. Several mechanisms are at play:

Sleep-disordered breathing: Women with PCOS have a 5–30× greater prevalence of obstructive sleep apnea compared to BMI-matched controls without PCOS, driven partly by androgen effects on upper airway muscles and partly by central adiposity (Tasali et al., Journal of Clinical Endocrinology & Metabolism 2008; PMID: 17940118). Sleep apnea fragments sleep architecture and produces non-restorative sleep even when total hours appear adequate.

HPA axis dysregulation: Cortisol secretion patterns are abnormal in a subset of women with PCOS. Elevated evening cortisol raises core body temperature and suppresses melatonin onset, directly lengthening sleep latency. Insulin resistance itself worsens HPA reactivity, creating a bidirectional relationship between sleep quality and metabolic dysfunction.

Mood and anxiety co-morbidity: The prevalence of anxiety and depression in PCOS is roughly 2× that of the general female population (Benson et al., Fertility and Sterility 2009). Both conditions independently disrupt sleep architecture, particularly REM sleep.

If you've struggled with poor sleep for years alongside other PCOS symptoms, it's worth specifically asking your clinician about a sleep study — sleep apnea in women is frequently underdiagnosed because presentations differ from the classic male pattern.

---

What About Inositol and Other Evidence-Based Interventions?

Once PCOS is confirmed, the evidence-based first-line interventions differ by symptom phenotype. For insulin resistance and cycle regularity, myo-inositol (2–4 g/day) has the most consistent trial evidence: a 2012 randomized controlled trial in 120 PCOS women found myo-inositol reduced fasting insulin, improved menstrual regularity, and restored ovulation in a significant proportion of participants within 12–16 weeks (Gerli et al., Gynecological Endocrinology 2007; PMID: 17505958). You can explore whether inositol helps with PCOS and the clinical evidence in depth.

For androgen-driven symptoms such as hirsutism and acne, spearmint tea and saw palmetto have modest but real evidence. Magnesium is a reasonable add-on: women with PCOS are significantly more likely to be deficient in magnesium, and correcting that deficiency improves insulin sensitivity markers. If you want to understand whether magnesium helps with PCOS, the mechanism runs through GLUT4 transporter expression and insulin receptor phosphorylation — genuine cellular pathways, not vague anti-inflammatory effects.

B vitamins — particularly B6, folate (as methylfolate for women with MTHFR variants), and B12 — support homocysteine metabolism, which is frequently elevated in PCOS and independently associated with cardiovascular risk. B vitamins and their role in PCOS are worth understanding if your labs show elevated homocysteine.

---

What This Means for Your Formula

Ones uses AI-analyzed blood work, wearable data, and health history to build a personalized daily capsule formula rather than recommending a generic women's health multi. For someone presenting with confirmed PCOS or strong clinical suspicion, three ingredients are particularly relevant based on the mechanisms described above:

• Myo-Inositol: Dosed at the clinically validated 2–4 g range used in PCOS RCTs, addressing insulin sensitivity and menstrual cycle restoration through the phosphatidylinositol signaling pathway.
• Magnesium Glycinate (as part of the Magnesium Complex blend): Women with PCOS show significantly lower serum magnesium than healthy controls. Magnesium glycinate is the form with the best absorption and the lowest GI side-effect burden, relevant when GI sensitivity (including nausea) is already present.
• Zinc: Androgen excess in PCOS is partly mediated through 5-alpha-reductase activity. Zinc inhibits this enzyme at doses of 25–50 mg, reducing conversion of testosterone to the more potent DHT — directly relevant to acne and hirsutism management.

Ones formulas are calibrated to a 6 or 9-capsule daily plan by the AI based on the full picture of your findings, not chosen by you from a menu, which means the ingredient stack adjusts to your specific phenotype rather than defaulting to a generic PCOS protocol.

---

Key Takeaways

• Diagnosis requires two of three Rotterdam criteria: irregular cycles, hyperandrogenism, or polycystic ovarian morphology — not all three simultaneously.
• Polycystic ovaries on ultrasound alone do not equal PCOS — up to 25% of women without PCOS have this finding.
• Critical mimics must be ruled out first: androgen-secreting tumors, CAH, Cushing's syndrome, and hyperprolactinemia can all look like PCOS.
• Insulin resistance is present in 65–80% of PCOS cases regardless of weight — fasting insulin and HOMA-IR are essential tests even if your clinician doesn't initially order them.
• Nausea, dizziness, and insomnia are real PCOS symptoms with documented mechanisms; they deserve investigation, not dismissal.
• Evidence-based interventions exist: inositol, magnesium, zinc, and B vitamins all have mechanistic and clinical trial support — the right combination depends on your specific phenotype and lab findings.

Always consult a qualified healthcare provider for diagnosis and individualized treatment. The information in this article is educational and does not constitute medical advice.